ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PYPD vs APYX // FORWARD P/E MULTIPLE

PolyPid Ltd. (NASDAQ) VS. Apyx Medical Corporation (NASDAQ) • 15-METRIC TALLY: PYPD 2 — APYX 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PYPD VS. APYX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PYPD APYX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 62.50% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -28.90% -6.10 APYX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -24.74% -8.04% -16.70 APYX /fcf-yield <GO>
Operating Margin — -12.20% — TIE /operating-margins <GO>
Net Profit Margin — -21.20% — TIE /net-margins <GO>
Revenue Growth (YoY) — 9.90% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.75 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 5/9 -3.00 APYX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.3 49.1 +10.15 PYPD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $113.5M $113.3M $229.2K PYPD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PYPD REV APYX REV PYPD GROSS % APYX GROSS % PYPD FCF APYX FCF
FY 2025 $0 $52.8M — 62.5% -$28.1M -$9.1M
FY 2024 $0 $48.1M — 61.0% -$22.0M -$18.8M
FY 2023 $0 $52.3M — — -$17.2M -$5.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PYPD // BETA —
APYX // BETA —